Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

377 Press Releases
DateTitleCompany
08 Apr 13 Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Mar 13 Teva to Present at the 2013 Barclays Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 Mar 13 Teva Files 2012 Annual Report on Form 20-F Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Mar 13 Teva Calls 5.550% Senior Notes Due 2016 for Redemption Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Feb 13 Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Feb 13 Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Feb 13 Teva Announces FDA Approval of Generic Adderall XR® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
11 Feb 13 Teva Pharmaceuticals Announces Appointment of Dr. Arie Belldegrun to Board of Directors Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Feb 13 Teva Reports Fourth Quarter and Full Year 2012 Results Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Feb 13 Teva Announces First Patient Enrolled in Largest Clinical Study to Date Evaluating AZILECT® for Mild Cognitive Impairment in Parkinson's Disease Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 Jan 13 Teva Announces Termination of Agreements with CureTech Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Jan 13 Teva Reports Top-Line Results from Second Phase III Study of Armodafinil (NUVIGIL®) in Patients with Major Depression Associated with Bipolar 1 Disorder Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Jan 13 Teva to Report Fourth Quarter and Full Year 2012 Financial Results on February 7, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Jan 13 Teva to Present at the 31st Annual J.P. Morgan Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Dec 12 Teva Calls 1.700% Senior Notes Due 2014 for Redemption Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Dec 12 Teva Signs New $3.0 Billion Syndicated Revolving Credit Facility Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Dec 12 Teva Enters Agreement with Handok to Establish Business Venture with Significant Presence in Korean Pharmaceutical Market Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
11 Dec 12 Teva and Xenon Announce Teva’s World Wide License of Xenon’s Pain Drug XEN402 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
26 Oct 12 Teva Receives Approval For SYNRIBOTM (Omacetaxine Mepesuccinate) for Injection Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Nov 12 Teva to Host Conference Call and Webcast on November 30, 2012 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Nov 12 Teva Provides 2013 Non-GAAP Financial Outlook Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Dec 12 Teva Invites the Public to Listen to Its 2012 Investor Meeting Webcast Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
22 Oct 12 Phase IIa Laquinimod Trial Results Show Positive Data for Potential Use in Active Crohn's Disease Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Oct 12 Teva to Present Positive Data for Glatiramer Acetate 40 mg/1 ml Given Three Times Weekly for Relapsing-Remitting Multiple Sclerosis Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Oct 12 Teva to Present Positive Data for Glatiramer Acetate 40 mg/1 ml Given Three Times Weekly for Relapsing-Remitting MS Teva Pharmaceutical Industries Ltd.
08 Oct 12 New Data Presented at the 28th ECTRIMS Congress Showcase Teva’s Ongoing Commitment to Multiple Sclerosis Research Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Oct 12 Teva to Report Third Quarter 2012 Financial Results on November 1, 2012 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Nov 12 Teva Reports Third Quarter 2012 Results Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 Nov 12 Teva Announces Changes to Executive Leadership Team Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Sep 12 Bayer HealthCare to Acquire U.S. Animal Health Business From Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.